Lymphoma Classification

Slides:



Advertisements
Similar presentations
The WHO Classification of Hematological Malignancies
Advertisements

PATHOLOGY OF THE PRIMARY CUTANEOUS T-CELL LYMPHOMA
Non-Hodgkin’s Lymphoma
Edoardo Pescarmona Dipartimento di Medicina Sperimentale
Rick Allen.  Leukaemia involves widespread bone marrow involvement and a presence in peripheral blood.  Lymphoma’s arise in discrete tissue masses (commonly.
LYMPHOMAS By DR : Ramy A. Samy.
Proposed WHO Classification of Lymphoid neoplasm
2010 Hematopoietic and Lymphoid Neoplasm Project Issues, Timing and Transformations.
Non-Hodgkin’s Lymphoma
By the end of this session you should know:
Lymphoma Dr. Raid Jastania Dec By the end of this session you should be able to: –Discuss the basis of the classification of lymphomas –Know the.
Primary Cutaneous Lymphoma Heterogeneous group of T and B-cell lymphomas variation in –clinical presentation –histology –immunophenotype –prognosis Incidence.
Week 11: Lymphoproliferative Disorders Multiple myeloma Multiple myeloma Plasma cell Plasma cell Monoclonal gammopathy Monoclonal gammopathy Bence-Jones.
Non-Hodgkin lymphoma. Non-Hodgkin’s lymphoma Definition: - clonal tumours of mature and immature B cells, T cells or NK cells - highly heterogeneous,
Lymphoma Presentation and Diagnosis Mark B. Juckett MD Division of Hematology University of Wisconsin June 19, 2003.
DIAGNOSING LYMPHOMA AND THE GMCHMDS
Lymphomas Clonal disorders of lymphoid cells at various stages of differentiation HODGKIN L. NON-HODGKIN L.  immature cells (precursors)  mature cells.
MRS GE.  72 years old retired Market Researcher.  3 month history of increasing fatigue associated with one week of drenching night sweats.  B/G: URTI.
Lymphoma Nada Mohamed Ahmed , MD, MT (ASCP)i.
LYMPHOMA.
Malignant lymphomas.
Goals Understand the differences between Hodgkin Lymphoma and non-Hodgkin Lymphoma Clinically and biologically Understand the differences between aggressive.
Lymphoma DR: Gehan Mohamed.
Lymphomas & Leukemias General Pathology Histogenetic Classification
Non-Hodgkin’s lymphomas-definition and epidemiology
M. Mahmood Khan, MD Hematology-Oncology 12/5/03
HODGKIN LYMPHOMA. Classifications 1% Hodgkin lymphoma 1% of all cancers Arises in lymph nodes –(tons., Wald., EXN rare) Spreads predictably characteristically.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Lymphoma & other HIV-related malignancies
Lymphoma : Malignancy of Lymphocytes Lymphocytes B-cells T-cells NK-cells (Natural Killer Cells)
Leukopenia, leukocytosis
LYMPHOID NEOPLASMS.
Haematological Neoplasia:
EYAD F. ALSAEED MD, FRCPC ASSISTANT PROFESSOR, COLLEGE OF MEDICINE,KSU CONSULTANT RADIATION ONCOLOGY, KKUH ACTING HEAD HEMATOLOGY / ONCOLOGY UNIT DEPARTMENT.
L YMPHOMA FOR THE G ENERALIST Lee Berkowitz, MD. G OALS AND O BJECTIVES 1. Understand the importance of pathology and staging in the approach to management.
Treatment of Non- Hodgkin’s Lymphoma. Precursor B cell Lymphoblastic Leukemia Remission induction with combination therapy Consolidation phase: –High.
Hematopoietic and Lymphoid Neoplasm Project. Introduction to the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues 4 th edition 2.
T-cell lymphoma A. Precursor T-cell lymphomas
Lymphoma D S O’Briain February Lymphadenopathy Enlarged lymph nodes Benign: soft, mobile, tender, Malign: hard, fixed, 1. Reactive hyperplasia (lymphadenitis),
© Cancer Research UK 2005 Registered charity number Table One: Numbers and rates of new cases, non-Hodgkin lymphoma, UK, 2006 EnglandWalesScotlandN.IrelandUK.
Hematopoietic and lymphoreticular system
Hodgkin lymphomas Monirath Hav, MD, PhD fellow Pathology Department Ghent University Hospital Adapted from WHO Classification of Tumours of Haematopoietic.
HODGKIN ’ S LYMPHOMA Introduction Lymphocyte Predominance Classical HL  Nodular Sclerosis  Mixed cellularity  Lymphocyte rich  Lymphocyte depletion.
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
Non Hodgkin”s Lymphoma -- Histology appearance -- Cell of orgin -- Immunophenotype -- Molecular biology -- Clinical featres -- Prognosis -- Out-come of.
Myeloproliferative Lymphoproliferative & Immunoproliferative disorders.
ANOTHER LUMP IN THE NECK
Cellular origin of lymphoma
GASTROINTESTINAL MALT LYMPHOMA Scott R. Owens, M.D.
by Elaine S. Jaffe, Nancy Lee Harris, Harald Stein, and Peter G
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
Lymphoma Zhong Hua Hematological Dept. Renji Hospital.
LYMPHOMAS H.A MWAKYOMA, MD.
Cellular origin of lymphoma
Malignant lymphomas (Non-Hodgkin's lymphomas-NHLs)
CASE OF THE MONTH Dr Narender Tejwani Consultant ( Hematopathologist)
Dr.Hussein Alatabi MBChB,DCH,FICMS,CABP
Lymphoma/CLL 101: Know your Subtype
Lymphoma Most present as tumor Involving lymph nodes or other lymphoid organs such as the spleen. But extra nodal presentation may seen. Hodgkin’s Lymphoma.
MLAB Hematology Keri Brophy-Martinez
Non-Hodgkin’s Lymphoma Thomas Kochuparambil 10/20/10
Changes to the Hematopoietic and Lymphoid Neoplasm Coding Manual
by Paolo Strati, and Tait D. Shanafelt
T-cell NHL: US Perspective
Focus on lymphomas Cancer Cell
Lymphoma Ali Al Khader, M.D. Faculty of Medicine
Peripheral T Cell Lymphoma Prognostic Factors
Supplementary Fig. 1 KD 29 (+)
B lymphocytes: how they develop and function
Presentation transcript:

Lymphoma Classification Lymphoma first used in 1858 Old terminology Hodgkin’s Disease Lymphosarcoma Reticulum cell sarcoma Giant follicle lymphoma

Rye Classification Classification for Hodgkin’s Disease Conference in Rye NY 1965 Modification of Lukes-Butler classification Divided HD into four histologic types

Rye Classification Lymphocyte predominance (LP) Nodular sclerosis (NS) Mixed cellularity (MC) Lymphocyte depletion (LD)

Rappaport Classification Rappaport proposed classification in 1966 Nodular or Diffuse Lymphocytic, well differentiated Lymphocytic, poorly differentiated Mixed lymphocytic-histiocytic Histiocytic Undifferentiated

Modified Rappaport Classification Nodular Lymphocytic, poorly differentiated Mixed lymphocytic-histiocytic Histiocytic

Modified Rappaport Classification Diffuse Lymphocytic, well differentiated Lymphocytic, intermediate differentiation Lymphocytic, poorly differentiated Mixed lymphocytic-histiocytic Undifferentiated, Burkitt’s type Undifferentiated, non-Burkitt’s type Histiocytic Lymphocytic

New Classification Schemes British National Lymphoma Investigation (1974) Lukes and Collins (1974) Dorfman (1974) Kiel (1974) World Health Organization (1976)

Lukes and Collins Classification Attempt to correlate lymphoma to current understanding of normal immune system proposed immunologic subtypes could be recognized by morphology

Lukes and Collins Classification Undefined cell type T cell types Small lymphocytic Mycosis fungoides / Sezary syndrome (cerebriform) Convoluted lymphocytic Immunoblastic sarcoma (T cell) Histiocytic Unclassifiable

Lukes and Collins Classification B cell types Small lymphocytic Plasmacytoid lymphocytic Follicular center cell small cleaved large cleaved small noncleaved large noncleaved Immunoblastic sarcoma (B cell)

Kiel Classification Proposed by Lennert and a European consortium Updated in 1988

Kiel Classification Low Grade Malignancy Lymphocytic Lymphoplasmacytoid Centrocytic Centroblastic-centrocytic Follicular Follicular and Diffuse Diffuse

Kiel Classification High Grade Malignancy Centroblastic Lymphoblastic Burkitt’s type Convoluted cell type Immunoblastic

Updated Kiel Classification (B Cell) Low Grade Lymphocytic: CLL, PLL and hairy cell leukemia Lymphoplasmacytic/cytoid (LP immunocytoma) Plasmacytic Centroblastic/centrocytic follicular diffuse Centrocytic

Updated Kiel Classification (B Cell) High Grade Centroblastic Immunoblastic Large Cell Anaplastic (Ki-1) Burkitt’s lymphoma Lymphoblastic Rare Types

Updated Kiel Classification (T Cell) Low Grade lymphocytic: CLL and PLL Small cerebriform cell: MF and SS Lymphoepithelioid (Lennert’s lymphoma) Angioimmunoblastic (AILD) T zone Pleomorphic, small cell (HTLV 1+/-)

Updated Kiel Classification (T Cell) High Grade Pleomorphic, medium and large cell ( HTLV 1 +/-) Immunoblastic (HTLV 1 +/-) Large cell anaplastic (Ki 1 ) Lymphoblastic Rare Types

Working Formulation Collaborative international study sponsored by NCI Published new terminology in 1982 A Working Formulation of Non-Hodgkin’s Lymphoma for Clinical Usage Not a new classification but a means o translation from one classification to another

Working Formulation - Low Grade A. Malignant lymphoma (small lymphocytic) Consistent with CLL Plasmacytoid B. Malignant lymphoma, follicular (predominantly small cleaved cell) Diffuse areas Sclerosis C. Malignant lymphoma, follicular (mixed, small cleaved and large cell)

Working Formulation - Intermediate Grade D. Malignant lymphoma, follicular (predominantly large cell) Diffuse areas Sclerosis E. Malignant lymphoma, diffuse (small cleaved cell) F. Malignant lymphoma, diffuse (mixed, small and large cell) Epithelioid cell component G. Malignant lymphoma, diffuse (large cell) Cleaved cell Noncleaved cell

Working Formulation - High Grade H. Malignant lymphoma (large cell, immunoblastic) Plasmacytoid Clear cell Polymorphous Epithelioid cell component I. Malignant lymphoma (lymphoblastic) Convoluted cell Nonconvoluted cell J. Malignant lymphoma (small noncleaved cell) Burkitt’s Follicular areas

Working Formulation - Miscellaneous Composite Mycosis fungoides Histiocytic Extramedullary plasmacytoma Unclassifiable Other

Revised European-American Lymphoma Classification Consensus conference in Berlin Germany in 1993 19 hematopathologists - The International Lymphoma Study Group Define diseases which can be reliably recognized with currently available morphologic, immunologic, and genetic techniques

Revised European-American Lymphoma Classification B-Cell Neoplasms I. Precursor B-cell neoplasm: B-precursor lymphoblastic leukemia/lymphoma II. Peripheral B-cell neoplasms T-Cell and Putative NK-Cell Neoplasms I. Precursor T-cell neoplasms: T-precursor lymphoblastic leukemia/lymphoma II. Peripheral T-cell and NK-cell neoplasms Hodgkin’s Disease

Revised European-American Lymphoma Classification Peripheral B-cell Neoplasms B-cell chronic lymphocytic leukemia/prolymphocytic leukemia/small lymphocytic lymphoma Lymphoplasmacytoid lymphoma/immunocytoma Mantle cell lymphoma

Revised European-American Lymphoma Classification Peripheral B-cell Neoplasms Follicle center lymphoma Provisional cytologic grades: I (small cell), II (mixed small and large cell), III (large cell) Provisional subtype: diffuse, predominantly small cell type

Revised European-American Lymphoma Classification Peripheral B-cell Neoplasms Marginal zone B-cell lymphoma Extranodal (MALT type +/- monocytoid B cells) Provisional category: nodal (+/- monocytoid B cells) Provisional entity: splenic marginal zone lymphoma (+/- villous lymphocytes) Hairy cell leukemia Plasmacytoma/myeloma

Revised European-American Lymphoma Classification Peripheral B-cell Neoplasms Diffuse large B-cell lymphoma Subtype: primary mediastinal (thymic) B-cell lymphoma Burkitt’s lymphoma Provisional category: high-grade B-cell lymphoma, Burkitt’s-like

Revised European-American Lymphoma Classification T-Cell and Putative NK-Cell Neoplasms T-cell chronic lymphocytic leukemia/prolymphocytic leukemia Large granular lymphocytic leukemia (LGL) T-cell type NK-cell type Mycosis fungoides/Sezary syndrome

Revised European-American Lymphoma Classification T-Cell and Putative NK-Cell Neoplasms Peripheral T-cell lymphomas, unspecified Provisional cytologic categories: medium sized cell, mixed medium and large cell, large cell, lymphoepithelioid cell Provisional subtype: Hepatosplenic gd T-cell lymphoma Provisional subtype: Subcutaneous panniculitic T-cell lymphoma

Revised European-American Lymphoma Classification T-Cell and Putative NK-Cell Neoplasms Angioimmunoblastic T-cell lymphoma Angiocentric lymphoma Intestinal T-cell lymphoma (+/- enteropathy associated) Adult T-cell leukemia/lymphoma

Revised European-American Lymphoma Classification T-Cell and Putative NK-Cell Neoplasms Anaplastic large cell lymphoma (ALCL), CD30+ T- and null cell types Provisional entity: Anaplastic large cell lymphoma, Hodgkin’s-like

Revised European-American Lymphoma Classification Hodgkin’s Disease Lymphocyte predominance Nodular sclerosis Mixed cellularity Lymphocyte depletion Provisional entity: Lymphocyte-rich classical Hodgkin’s Disease